Where does Elira, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Elira, Inc. ranks #21,066 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Elira, Inc. hold?

Elira, Inc. holds 13 US utility patents granted between 2018 and 2022, spanning 6 technology areas.

What is Elira, Inc.'s Innovation Score?

Elira, Inc. has an Innovation Score of 35.0 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Elira, Inc. focus on?

Elira, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 12 patents, ranking #298 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Elira, Inc.'s patent grant rate increasing or decreasing?

Elira, Inc.'s recent grant velocity is -37% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Elira, Inc.'s patents?

Elira, Inc.'s patents average 37.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Elira, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Elira, Inc.

USPTO PatentsView assignee record - 13 granted patents across 6 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Elira ranks #21,066 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 6 technology areas.

#21,066
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (35.0/100): 37.5
avg claims per patent: -37%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21066 · US Corporation #21,066 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,066/49,997
PHOTO-FINISH Ekornes ASA
CPC-NARROW A61N · 6 areas
INNOV-THIN 35.0/100
CLAIMS-DENSE 37.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -37% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ekornes ASA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Elira’s 35.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (26%) Velocity 2.2 pts (6%) Breadth 8.7 pts (25%) Claim depth 15.0 pts (43%)

Qualcomm Incorporated · highest

85
Caroma Industries · near

35
Colebrook Bosson &… · near

35
Elira · this assignee

35
Modernfold · near

35
TBS Engineering · near

35
3D Lighting… · lowest

7

What this shows Elira's Innovation Score is 35.0/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Elira?

Each dot is one of Elira’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Elira’s own 37.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Elira vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Elira's grants concentrate

Elira, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 92.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2021. By volume, Elira sits between Ekornes ASA and Emerson Automation Solutions Final Control US LP.

Elira's three-year grant acceleration

Elira, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ekornes ASA

13
Electric Power Sc…

13
Electrical Materi…

13
Warfare Associates

13
Eliza

13
Emblation

13
Embolx

13
Emerson Automatio…

13
Elira ◀

13

What this shows Elira holds 13 patents at rank #21,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Elira

By rank, the assignees closest to #21,083 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Elira's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Elira, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Elira ranks #298 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

TBS Engineering Limited 35 Modernfold, Inc. 35 Colebrook Bosson & Saunders (Products) Limited 35 Caroma Industries Limited 35

Elira's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Elira, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	5	38.5%
2019	3	23.1%
2020	2	15.4%
2021	1	7.7%
2022	2	15.4%

Which technologies does Elira, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 12

A61B - DIAGNOSIS; SURGERY; Identification 10

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Elira, Inc.'s patent record in context - here's where to go next.

Elira, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 92.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #21,066 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Elira, Inc. against Ekornes ASA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.